| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
CA: A Cancer Journal for Clinicians, Vol 49, Issue 4 231-255, Copyright © 1999 by American Cancer Society
Y. Fong
This review summarizes data demonstrating the safety and efficacy of liver
resection for colorectal metastases. Hepatic resection in appropriately
selected patients remains the only potentially curative treatment for
patients with such metastases. Recommendations for preoperative patient
evaluation, patient selection, adjuvant therapy, and postoperative
follow-up are presented. Other surgical modalities utilized in the
treatment of unresectable or recurrent hepatic colorectal metastases,
including ablative modalities and surgical delivery of regional
chemotherapy, are described.
ARTICLES
Surgical therapy of hepatic colorectal metastasis
Hepatobiliary Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
This article has been cited by other articles:
|
|
 |
|
  M. T. Lee, J. J. Kim, R. Dinniwell, J. Brierley, G. Lockwood, R. Wong, B. Cummings, J. Ringash, R. V. Tse, J. J. Knox, et al. Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases J. Clin. Oncol., April 1, 2009; 27(10): 1585 - 1591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Jia, C. O'Dell, J. T. Heverhagen, X. Yang, J. Liang, R. V. Jacko, S. Sammet, T. Pellas, P. Cole, and M. V. Knopp Colorectal Liver Metastases: Contrast Agent Diffusion Coefficient for Quantification of Contrast Enhancement Heterogeneity at MR Imaging Radiology, September 1, 2008; 248(3): 901 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ychou, D. Azria, C. Menkarios, P. Faurous, F. Quenet, B. Saint-Aubert, P. Rouanet, M. Pelegrin, C. Bascoul-Mollevi, D. Guerreau, et al. Adjuvant Radioimmunotherapy Trial with Iodine-131-Labeled Anti-Carcinoembryonic Antigen Monoclonal Antibody F6 F(ab')2 after Resection of Liver Metastases from Colorectal Cancer Clin. Cancer Res., June 1, 2008; 14(11): 3487 - 3493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Rahman, J. Evans, G. J. Toogood, P. A. Lodge, and K. R. Prasad Prognostic Utility of Postoperative C-reactive Protein for Posthepatectomy Liver Failure Arch Surg, March 1, 2008; 143(3): 247 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Gulec and Y. Fong Yttrium 90 Microsphere Selective Internal Radiation Treatment of Hepatic Colorectal Metastases Arch Surg, July 1, 2007; 142(7): 675 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Winston, N. A. Lee, W. R. Jarnagin, J. Teitcher, R. P. DeMatteo, Y. Fong, and L. H. Blumgart CT Angiography for Delineation of Celiac and Superior Mesenteric Artery Variants in Patients Undergoing Hepatobiliary and Pancreatic Surgery Am. J. Roentgenol., July 1, 2007; 189(1): W13 - W19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Alberts, W. L. Horvath, W. C. Sternfeld, R. M. Goldberg, M. R. Mahoney, S. R. Dakhil, R. Levitt, K. Rowland, S. Nair, D. J. Sargent, et al. Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study J. Clin. Oncol., December 20, 2005; 23(36): 9243 - 9249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Akhurst, T. J. Kates, M. Mazumdar, H. Yeung, E. R. Riedel, B. M. Burt, L. Blumgart, W. Jarnagin, S. M. Larson, and Y. Fong Recent Chemotherapy Reduces the Sensitivity of [18F]Fluorodeoxyglucose Positron Emission Tomography in the Detection of Colorectal Metastases J. Clin. Oncol., December 1, 2005; 23(34): 8713 - 8716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Liersch, J. Meller, B. Kulle, T. M. Behr, P. Markus, C. Langer, B. M. Ghadimi, W. A. Wegener, J. Kovacs, I. D. Horak, et al. Phase II Trial of Carcinoembryonic Antigen Radioimmunotherapy With 131I-Labetuzumab After Salvage Resection of Colorectal Metastases in the Liver: Five-Year Safety and Efficacy Results J. Clin. Oncol., September 20, 2005; 23(27): 6763 - 6770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Turrini, J. Guiramand, V. Moutardier, F. Viret, E. Bories, M. Giovannini, N. Pernoud, J.-L. Blache, and J.-R. Delpero Liver does not care about age Ann. Onc., May 1, 2005; 16(5): 836 - 837. [Full Text] [PDF]
|
|
|
|
|
|
T. Delaunoit, S. R. Alberts, D. J. Sargent, E. Green, R. M. Goldberg, J. Krook, C. Fuchs, R. K. Ramanathan, S. K. Williamson, R. F. Morton, et al. Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741 Ann. Onc., March 1, 2005; 16(3): 425 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Sharkey and D. M. Goldenberg Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies J. Nucl. Med., January 1, 2005; 46(1_suppl): 115S - 127S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pozzo, M. Basso, A. Cassano, M. Quirino, G. Schinzari, N. Trigila, M. Vellone, F. Giuliante, G. Nuzzo, and C. Barone Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients Ann. Onc., June 1, 2004; 15(6): 933 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Covey, L. A. Brody, M. A. Maluccio, G. I. Getrajdman, and K. T. Brown Variant Hepatic Arterial Anatomy Revisited: Digital Subtraction Angiography Performed in 600 Patients Radiology, August 1, 2002; 224(2): 542 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Bilchik, T. F. Wood, D. Allegra, G. J. Tsioulias, M. Chung, D. M. Rose, K. P. Ramming, and D. L. Morton Cryosurgical Ablation and Radiofrequency Ablation for Unresectable Hepatic Malignant Neoplasms: A Proposed Algorithm Arch Surg, June 1, 2000; 135(6): 657 - 664. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
